Lpath, Inc.
San Diego, CA, US· latest recorded location
Lpath, Inc. is named on 23 US grants and 28 published applications in this corpus. Its most frequent classification is C07K (Peptides).
- Granted patents
- 23
- Published applications
- 28
- Inventors
- 17
- Granted in 2026 so far
- 0
- Most recent grant
- 1 Mar 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 3 |
| 2008 | 0 | 2 |
| 2009 | 0 | 7 |
| 2010 | 2 | 4 |
| 2011 | 6 | 3 |
| 2012 | 2 | 3 |
| 2013 | 5 | 1 |
| 2014 | 2 | 0 |
| 2015 | 4 | 2 |
| 2016 | 2 | 2 |
By publication year.
Technology areas
Share of 51 documents
- C07KPeptides51
- A61KMedicines and medical preparations49
- A61PTherapeutic uses of medicines45
- G01NInvestigating or analysing materials by determining their chemical or physical properties19
- C12NMicroorganisms or enzymes5
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2
- G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or2
Recent patents
- Methods and reagents for detecting bioactive lipids1 Mar 2016US 9,274,129 B2
- Prevention and treatment of pain using antibodies to lysophosphatidic acid1 Mar 2016US 9,274,130 B2
- Immune-derived moieties reactive against lysophosphatidic acid22 Dec 2015US 9,217,749 B2
- Pharmaceutical compositions for binding sphingosine-1-phosphate10 Nov 2015US 9,181,331 B2
- Compositions and methods for binding lysophosphatidic acid20 Oct 2015US 9,163,091 B2
- Prevention and treatment of pain using antibodies to lysophosphatidic acid16 Jun 2016US 2016/0168270 A1
- Compositions and methods for binding lysophosphatidic acid26 May 2016US 2016/0146844 A1
- Prevention and treatment of pain using antibodies to sphingosine-1-phosphate23 Jul 2015US 2015/0203570 A1
- Novel bioactive lipid derivatives, and methods of making and using the same29 Jan 2015US 2015/0031055 A1
- Anti-s1p antibody treatment of patients with ocular disease7 Mar 2013US 2013/0058951 A1
Most cited
By later US patents
- Compositions and methods for binding sphingosine-1-phosphate12US 7,829,674 B22010
- Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation7US 7,901,682 B22011
- Compositions and methods for treating sphingosine-1-phosphate (S1P) related ocular diseases and conditions5US 8,614,103 B22013
- Compositions and methods for binding lysophosphatidic acid4US 8,158,124 B22012
- Humanized antibody compositions and methods for binding lysophosphatidic acid4US 8,604,172 B22013